Expression of 65-kDa oncofetal protein in experimental hepatoma after anticancer therapy

Neoplasma

Volumn 44, Issue 2, 1997, Pages 85-89

  Mirowski, M ^a   Rozalski, M ^a   Krajewska, U ^a   Hanausek, M ^b   Wierzbicki, R ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

menadione; methotrexate; p65 oncofetal protein; polyclonal anti p65 antibody

Indexed keywords

MENADIONE; METHOTREXATE; ONCOFETAL ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; HAMSTER; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; MALE; NONHUMAN; RADIOIMMUNOASSAY;

EID: 0030978073     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. BRADFORD, M.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem., 72, 1976, 248-254.
2. 3 and warfarin to enhance antimetabolic effects in cancer: Laboratory and clinical observations. Curr. Chemother. Immunother., 2, 1981, 1532-1533.
3. DRZEWOSKI, J., ROBAK, T.: Clinical Pharmacology of Anticancer Drugs. Warszawa, Wyd. Nauka. 1991. (In Polish.)
4. 3 and methotrexate in tumorbearing animals. Cancer Treat Rep., 70, 1986, 1433-1435.
5. GREENWOOD, F.C., HUNTER, W.M., GLOVER, J.S.: The preparation of 131I-labelled human growth hormone of high specifific radioactivity. Biochem. J., 89, 1963, 114-123.
6. cdc2 kinase and phosphatase. Biochem. Biophys. Res. Commun., 190. 1993, 907-913.
7. MIROWSKI, M., HANAUSEK, M., SHERMAN, U., ADAMS, A.K., WALASZEK, Z., SLAGA, T.J.: An enzyme-linked immunosorbent assay for p65 oncofetal protein and its potential as a new marker for cancer risk assessment in rodents and humans. Prog. Clin. Biol. Res., 374, 1991, 281-294.
8. MIROWSKI, M., SHERMAN, U., HANAUSEK, M.: Purification and characterization of a 65-kDa tumor-associated phosphoprotein from rat transplantable hepatocellular carcinoma 1682C cell line. Protein. Exp. Purif., 3, 1992, 196-203.
9. MIROWSKI, M., WALASZEK, Z., SHERMAN, U., HANAUSEK, M.: Comparative structural analysis of human and rat 65 kDa tumor-associated phosphoproteins. Int J. Biochem., 25, 1993, 1865-1871.
10. MIROWSKI, M., WALASZEK, Z., SHERMAN, U., ADAMS, K.A., HANAUSEK, M.: Demonstration of a 65 kDa tumor-specific phosphoprotein in urine and serum of rats with N-methyl-N-nitrosourea-induced mammary adenocarcinomas. Carcinogenesis, 14, 1993, 1659-1664.
11. MIROWSKI, M., KLIJANIENKO, J., WANG, S., VIEHL, P., WALASZEK, Z., HANAUSEK, M.: Serological and immunohistochemical detection of a 65-kDa oncofetal protein in breast cancer. Eur. J. Cancer, 30A, 1994, 1108-1113.
12. MIROWSKI, M., WALASZEK, Z., HANAUSEK, M.: Presence in bovine fetal serum of the protein antigenically related to p65-tumor associated antigen: Its isolation and polyclonal antibodies production. Neoplasma, 43, 1996, 83-88.
13. READ, S.M., NORTHCOTE, D.H.: Minimization of variation in the response to different proteins of Coomassie Blue G dye-binding assay for protein. Anal. Biochem., 116. 1981, 53-64.
14. RITTER, K.: Affinity purification of antibodies from sera using polyvinylidenedifluoride (PVDF) membranes as coupling matrices for antigens presented by autoantibodies to triosephosphate isomerase. J. Immunol. Meth., 137. 1991, 209-215.
15. SCHIBLER, Y., WEBER, R.: A new method for the isolation of undegraded nuclear and cytoplasmic RNA from liver of Xenopus Larwae. Anal. Biochem., 58, 1974, 225-230.
16. TOWBIN, H., STAEHELIN, T., GORDON, J.: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci., 76, 1979, 4350-4354.
17. WANG, S.W., MIROWSKI, M., SHERMAN, U., WALASZEK, Z., HANAUSEK, M.: Monoclonal antibodies against a 65-kDa tumor-associated phosphoprotein: Development and use in cancer detection. Hybridoma, 12, 1993, 167-176.